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Background::  Genome sequencing and bioinformatics are producing detailed lists of the molec-
ular components contained in many prokaryotic organisms. From this ’parts catalogue’ of a micro-
bial cell, in silico representations of integrated metabolic functions can be constructed and analyzed
using flux balance analysis (FBA). FBA is particularly well-suited to study metabolic networks based
on genomic, biochemical, and strain specific information.
Results::  Herein, we have utilized FBA to interpret and analyze the metabolic capabilities of Es-
cherichia coli. We have computationally mapped the metabolic capabilities of E. coli using FBA and
examined the optimal utilization of the E. coli metabolic pathways as a function of environmental
variables. We have used an in silico analysis to identify seven gene products of central metabolism
(glycolysis, pentose phosphate pathway, TCA cycle, electron transport system) essential for aero-
bic growth of E. coli on glucose minimal media, and 15 gene products essential for anaerobic growth
on glucose minimal media. The in silico tpi -, zwf, and pta - mutant strains were examined in more
detail by mapping the capabilities of these in silico isogenic strains.
Conclusions::  We found that computational models of E. coli metabolism based on physicochem-
ical constraints can be used to interpret mutant behavior. These in silica results lead to a further
understanding of the complex genotype-phenotype relation.
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Figure 1
Growth phenotypes of in silico deletion strains; maximal bio-
mass yields on glucose for all possible single gene deletions in 
central intermediary metabolism. The environmental varia-
bles (uptake rate/external metabolic fluxes) are set to corre-
spond to a point within each of the phases of the wild-type 
PhPP (figure inset). The maximal yields were calculated using 
flux-balance analysis with the objective of maximizing the 
growth flux. The biomass yields are normalized with respect 
to the results for the full metabolic genotype. The α  and β  val-
ue for the constraints on the external fluxes for glucose and 
oxygen uptake are defined as follows (units- mmole g-1 hr-1): 
Phase 1 - v glc = 10, v oxy = 23; LO - v gic = 10, v oxy = 20.3; Phase 
2 - v glc = 10, v oxy = 17; Phase 3 - v glc = 10, v oxy = 12; Phase 
4 - v glc = 10, v oxy = 8; Phase 5 - v glc = 10, v oxy = 3; Phase 6 - 
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Phenotype Phase Plane Analysis
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Optimal production of the twelve biosynthetic precursors and the metabolic cofactors.
Compound µ mol/g DW Compound µ mol/g 
DW
Amino Acids Phospholipids
Alanine 488 Phosphatidyl 
serine
2.58
Arginine 281 Phosphatidyl 
ethanolamine
96.75
Asparagine 229 Phosphatidyl 
glycerol
23.22
Aspartate 229 Cardiolypin 6.45
Cysteine 87 Fatty acid 
composition 
(% of total 
fatty acid)
Glutamate 250 Myristic acid 
(2.68)
Glutamine 250 Myristoleic 
acid (7.70)
Glycine 582 Palmitic acid 
(38.23)





Leucine 428 cis-Vaccenic 
acid (0.90)









Serine 205 Peptidoglycan 27
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Valine 402 Spermidine 7.0




ATP 165 NADP 0.13









dATP 24.7 CoA 0.03
dTTP 24.7 Acetyl-CoA 0.04
dGTP 25.4 Succinyl-CoA 0.01




The optimal production was calculated for the wild-type strain and the deletion strains. The 
constraints are set as defined in Figure 1. The color code quantitatively defines effect of the 
in silico deletion; red corresponds to 0.0, yellow corresponds to 0-50% of the wild-type pro-
duction, blue corresponds to 50-100% of the wild-type, and no color coding is illustrated 
when the production is unchanged from the wild-type. Data for other carbon sources is avail-
able online. G6P, glucose-6-phosphate; F6P, fructose-6-phosphate; R5P, ribose-5-phosphate; 
E4P,erythrose 4-phosphate; T3P1, glyceraldehyde 3-phosphate; 3PG, 3-phosphoglycerate; 
PEP, phosphoenolpyruvate; PYR, pyruvate; ACCOA, acetyl-CoA; AKG, α -ketoglutarate; 
SUCCOA, succinyl-CoA; OA, oxaloacetate.
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Mutant strain phenotype phase plane analysis. The wild-type 
strain PhPP is shown in the thin lines for comparative purpos-
es. The glucose-oxygen PhPP was constructed for each of the 
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